Collection of ethnicity data in clinical research has been poor historically, but is essential to ensure that interventions are effective and safe across diverse populations. These data are needed to ...

AstraZeneca's baxdrostat demonstrated significant blood pressure reduction in a late-stage trial for treatment-resistant ...

The latest investor updates on stocks that are trending on Monday.

AstraZeneca said on Monday its experimental drug baxdrostat significantly lowered blood pressure in a late-stage trial of ...

AstraZeneca and Glencore shares today kept the FTSE 100 index in positive territory during a session of outperformance versus ...

A PERSON has died from plague just 24-hours after they showed up at hospital with symptoms, health officals have said. The victim was rushed to Flagstaff Medical Center in Arizona, US, showing ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

AstraZeneca’s $1.3 billion bet on CinCor Pharma and its mid-phase hypertension drug baxdrostat seems to have paid off based ...

(Alliance News) - AstraZeneca PLC on Monday said a test of its baxdrostat drug showed a "meaningful reduction" in hypertension. The Cambridge, England-based pharmaceutical and biotechnology firm ...

Ovarian Cancer Drugs Market grows as FDA, EMA fast-track advanced-stage therapies, boosting global approvals and innovation. Anurag Tiwari Orion Market Research Pvt Ltd + +91 91798 28694 email us here ...

European shares experienced a decline on Monday, primarily driven by the automobile sector, due to President Trump's threat ...

AstraZeneca’s (LON: AZN) experimental drug baxdrostat lowered blood pressure in patients with hard to treat hypertension, ...